Eli Lilly Expands Early Access to Retatrutide Following Patient Advocacy Eli Lilly has confirmed it will allow a broader range of patients to apply for early access to its unapproved obesity drug, retatrutide. The decision follows a report by STAT regarding a 79-year-old patient who previously received special access to the medication. The pharmaceutical company … Read more
Scientists are studying how chronic inflammation triggered by diseased gums and bacteria may contribute to systemic conditions including heart disease, diabetes, and cognitive decline, according to recent research. The emerging science connects oral health to whole-body wellness, challenging the traditional divide between medicine and dentistry. The Mouth-Body Connection: How Gum Disease Drives Systemic Inflammation Researchers … Read more
Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more
Eli Lilly and Company is acquiring biotech firm AtaiBeckley for an up-front payment of $2.8 billion to integrate the psychedelic drug candidate BPL-003 into its neuroscience portfolio. According to company terms, Lilly will pay $6.75 per outstanding share, with potential milestone payments reaching an additional $1 billion ($2.50 per share), according to the deal terms. … Read more
Johnson & Johnson (JNJ) shares are navigating a period of volatility as investors weigh the company’s pharmaceutical growth against broader market rotations and macroeconomic pressures. According to FactSet, the healthcare giant faces a critical test during its second-quarter earnings report, with analysts closely monitoring the performance of key oncology and immunology drugs to justify the … Read more
The 1916 polio epidemic in the United States, which claimed nearly 6,000 lives and left 20,000 people permanently paralyzed, serves as a historical baseline for modern infectious disease management. According to historical records, the crisis triggered extreme public health interventions, including the mass culling of animals and public movement restrictions. Today, global polio cases have … Read more
The Union Health Ministry has banned the manufacture, sale, and distribution of 16 fixed-dose combination (FDC) drugs in India with immediate effect. The Department of Health cited a lack of therapeutic justification and potential risks to patients, acting on recommendations from the Drugs Technical Advisory Board (DTAB) following a multi-year regulatory review. Why did the … Read more
Pope Leo XIV visited the National Center for Oncological Hadrontherapy (CNAO) in Pavia, Italy, on June 20, 2026, marking a high-profile intersection between advanced particle physics and clinical oncology. According to Vatican Media, the visit highlighted the facility’s role in treating complex, radioresistant tumors through synchrotron-generated ion beams, a technology that targets diseased cells while … Read more
The Korea Research Institute of Chemical Technology (KRICT) has launched the DEL CoreBank Platform, a public drug discovery service that uses DNA-Encoded Library (DEL) technology to screen tens of millions of compounds simultaneously. This platform provides domestic researchers with a faster, more cost-effective alternative to expensive overseas outsourcing, aiming to accelerate the discovery of drugs … Read more
Geopolitical Instability and the Evolution of Chemical Supply Chains Global petrochemical supply chains are currently managing dual pressures: escalating regional conflict in the Middle East and a structural shift toward resilient, localized manufacturing. Recent airstrikes between Iran and Israel have disrupted the fragile ceasefire, threatening petrochemical hubs like Mahshahr, while firms such as Formosa Petrochemical … Read more